Filing Details
- Accession Number:
- 0001209191-16-095502
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-03 18:35:54
- Reporting Period:
- 2016-02-01
- Filing Date:
- 2016-02-03
- Accepted Time:
- 2016-02-03 18:35:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1469443 | Arcadia Biosciences Inc. | RKDA | Agricultural Chemicals (2870) | 810571538 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1640658 | C. Vic Knauf | C/O Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis CA 95618 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-02-01 | 1,666 | $1.08 | 48,800 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-02-01 | 1,666 | $3.00 | 47,134 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-02-01 | 1,666 | $0.00 | 1,666 | $1.08 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
235,834 | 2018-06-30 | No | 4 | M | Direct |
Footnotes
- The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective December 14, 2015.
- This transaction was executed in multiple trades at prices ranging from $2.97 to $3.05. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The option is fully exercisable as of the date hereof.